TY - JOUR
T1 - Design and synthesis of semi-artificial myoglobin possessing DNA-binding peptides on heme propionates
AU - Sakamoto, Seiji
AU - Kudo, Kazuaki
PY - 2005/12/1
Y1 - 2005/12/1
N2 - Peptides possessing the DNA-binding capability were successfully introduced into myoglobin by a cofactor-reconstitution strategy. We have designed and synthesized an artificial iron-protoporphyrin IX (heme)-peptide conjugate, Heme(br) 2, which has covalently conjugated GCN4 basic region peptides at the heme propionate groups as an artificial DNA-binding site. The peptide Heme(br) 2 was inserted into apomyoglobin to give a peptide-conjugated myoglobin, Mb(br) 2. The UV-vis and circular dichroism spectra of Mb(br) 2 were comparable to those of native myoglobin, suggesting that the heme environment and three-dimensional structure of Mb(br) 2 were almost identical to those of native myoglobin. The size exclusion chromatography indicated that the Mb(br) 2 existed as a monomeric form in an aqueous solution and interacted with its target DNA sequence [c-AMP responsive element (CRE)]. The fluorescence study also revealed that the Mb(br) 2 bound CRE DNA effectively with 1/1 stoichiometry [affinity constant; 8.4 (±0.8) × 10 7 M -1]. Additionally, the CRE DNA-binding enhanced the peroxidase-like activity of Mb(br) 2, possibly due to the partial structural perturbation around the heme active-site. These results demonstrate that the chemical modification of prosthetic group with functional peptides can provide a new strategy for the design of semi-artificial proteins with engineered function.
AB - Peptides possessing the DNA-binding capability were successfully introduced into myoglobin by a cofactor-reconstitution strategy. We have designed and synthesized an artificial iron-protoporphyrin IX (heme)-peptide conjugate, Heme(br) 2, which has covalently conjugated GCN4 basic region peptides at the heme propionate groups as an artificial DNA-binding site. The peptide Heme(br) 2 was inserted into apomyoglobin to give a peptide-conjugated myoglobin, Mb(br) 2. The UV-vis and circular dichroism spectra of Mb(br) 2 were comparable to those of native myoglobin, suggesting that the heme environment and three-dimensional structure of Mb(br) 2 were almost identical to those of native myoglobin. The size exclusion chromatography indicated that the Mb(br) 2 existed as a monomeric form in an aqueous solution and interacted with its target DNA sequence [c-AMP responsive element (CRE)]. The fluorescence study also revealed that the Mb(br) 2 bound CRE DNA effectively with 1/1 stoichiometry [affinity constant; 8.4 (±0.8) × 10 7 M -1]. Additionally, the CRE DNA-binding enhanced the peroxidase-like activity of Mb(br) 2, possibly due to the partial structural perturbation around the heme active-site. These results demonstrate that the chemical modification of prosthetic group with functional peptides can provide a new strategy for the design of semi-artificial proteins with engineered function.
UR - http://www.scopus.com/inward/record.url?scp=33746236035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746236035&partnerID=8YFLogxK
U2 - 10.1246/bcsj.78.1749
DO - 10.1246/bcsj.78.1749
M3 - Article
AN - SCOPUS:33746236035
SN - 0009-2673
VL - 78
SP - 1749
EP - 1756
JO - Bulletin of the Chemical Society of Japan
JF - Bulletin of the Chemical Society of Japan
IS - 10
ER -